In order to assess if the identified kinases in the invasion assay correlate with expression levels in tumors from GC patients, mRNA and protein expression levels for FRK, DDR1, SIK2 and SRC were assessed in tumor samples from GC patients. This evidence concerns the gene FRK and neoplasm.